Biodegradable Implants for Long-term Antibody Drug Delivery (2022-050)
Monoclonal antibodies have become increasingly valuable for treatment of a variety of diseases, such as age-related macular degeneration, various cancers, and inflammatory diseases. While these drugs have proven effective, they have a short half-life, and thus require repeated injections on a biweekly, monthly, or bimonthly basis which places a significant...
Published: 8/30/2023
|
Updated: 8/30/2023
|
Inventor(s): Thomas (TJ) Waterkotte, Yoonjee Park
Keywords(s):
Category(s): Technology Classifications > Advanced Materials > Healthcare-related materials, Technology Classifications > Life Sciences > Biomedical, Technology Classifications > Life Sciences > Therapeutics > Protein Therapies, Technology Classifications > Life Sciences, Technology Classifications > Advanced Materials, Technology Classifications > Life Sciences > Therapeutics
|